Virksomhedsform
Anpartsselskab
Etableret
2019
Størrelse
Mikro
Ansatte
5
Omsætning
- DKK
Bruttofortj.
5.170.830 DKK
Primært resultat (EBIT)
236.665 DKK
Årets resultat
174.324 DKK
Egenkapital
692.312 DKK
annonce

Flere nøgletal og analyser?

Med en Bisbase Premium konto får du flere nøgletal for både virksomheder, koncerner og brancher samt adgang til eksklusive brancher indeholdende virksomheder nøje sammensat af eksperter. Og vil du lave dine egne analyser kan du også det! Det tager få minutter at få adgang - og det behøver ikke at koste dig noget!

Rang Årets resultat

Rang i branche
226/445
"Omkring gns"
Rang i Danmark
129.244/343.419
"Omkring gns"

Direktion top 3

Antti Koivula 1Direktør
Jukka Laukkonen 1Direktør

Legale ejere top 3

100%Aidian Oy

Tegningsregler

Selskabet tegnes af 2 direktører i forening

Stamoplysninger baseret på CVR

NavnAidian Denmark Aps
CVR40227288
AdresseØrestads Boulevard 73, 2300 København S
BrancheEngroshandel med medicinalvarer og sygeplejeartikler [464610]
Etableret04-02-2019 (5 år)
Første regnskabsperiode04-02-2019 til 31-12-2019
VirksomhedsformAnpartsselskab
Antal ansatte4 (årsværk:4)
ReklamebeskyttelseNej
Revision fravalgtJa
Regnskabsperiode01-01 til 31-12
Selskabskapital50.000 DKK
Vedtægter seneste04-02-2019

Formål

Selskabets formål er at drive virksomhed med salgs- og markedsføringsaktiviteter i relation til medicinsk og diagnostisk udstyr.

Regnskab

 202220212020
Valuta/enhed000' DKK000' DKK000' DKK
Omsætning
-
-
-
-
-
-
Bruttofortjeneste
5.171
-12%
5.880
+27%
4.613
-
Årets resultat
174
-8%
189
+16%
164
-
Egenkapital
692
+34%
518
+57%
329
-
Balance
2.058
-6%
2.189
+6%
2.070
-

Ledelsesberetning

The Company's principal activities The company provides sales and marketing services to its parent company Aidian Oy in country Denmark. Development in activities and financial matters The Company's Income Statement of the financial year 1 January 2022 - 31 December 2022 shows a result of DKK 174.324 and the Balance Sheet at 31 December 2022 a balance sheet total of DKK 2.057.621 and an equity of DKK 692.312. The Company's product portfolio structure was affected by Covid-19 pandemia. Also, the Company's business practices were affected via remote work. Material changes in the Company's operations and financial matters Except for the covid-19 effects mentioned above there is no material changes in the Company's operations and financial matters.

Development in activities and financial matters The Company's Income Statement of the financial year 1 January 2022 - 31 December 2022 shows a result of DKK 174.324 and the Balance Sheet at 31 December 2022 a balance sheet total of DKK 2.057.621 and an equity of DKK 692.312. The Company's product portfolio structure was affected by Covid-19 pandemia. Also, the Company's business practices were affected via remote work. , Development in activities and financial matters The Company's Income Statement of the financial year 1 January 2022 - 31 December 2022 shows a result of DKK 174.324 and the Balance Sheet at 31 December 2022 a balance sheet total of DKK 2.057.621 and an equity of DKK 692.312. The Company's product portfolio structure was affected by Covid-19 pandemia. Also, the Company's business practices were affected via remote work.
07-06-2023

Kort